Latest News

MUSC's pediatric/adult bone marrow transplant program is one of 12 across the U.S. that performed better than expected, according to a new report.

An MUSC children’s cancer specialist and other experts from across state find 11% improvement in childhood cancer survival over 25-year period.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Parents and providers often underestimate the fatigue that pediatric cancer patients are experiencing. An OT student created a coloring book to help.

The parents of millions of teens don't intend to vaccinate them against HPV, a virus that can cause six types of cancer.

Alex's Lemonade Stand awarded Dr. Jezabel Rodriguez Blanco a grant to research ways to prevent medulloblastoma relapse, a cancerous brain tumor in kids.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

MUSC initiative aims to increase human papillomavirus vaccination rates in underserved communities.

Adult and pediatric doctors pooled their expertise to ensure a young patient would have few physical reminders of an extraordinary lung cancer surgery.